Insider Actions for Deciphera Pharmaceuticals Inc.
– Purchase
– Sale
1
– Number of Transactions
Date
Name
Transaction
Value
| 03/21/2023 |
Steven L. Hoerter President and CEO; Director |
7,500 | Disposition at $15.57 per share. | 116,775 |
| 02/28/2023 |
Brightstar Associates LLC |
2,427,693 | 24,276 | |
| 02/16/2023 |
Daniel L. Flynn Chief Scientific Officer |
1,370 | Disposition at $15.1 per share. | 20,687 |
| 02/16/2023 |
Matthew L. Sherman EVP & Chief Medical Officer |
971 | Disposition at $15.1 per share. | 14,662 |
| 02/16/2023 |
Thomas P. Kelly Chief Financial Officer |
1,370 | Disposition at $15.1 per share. | 20,687 |
| 02/16/2023 |
Daniel C. Martin Chief Commercial Officer |
1,159 | Disposition at $15.1 per share. | 17,500 |
| 02/16/2023 |
Jama Pitman See Remarks |
1,159 | Disposition at $15.1 per share. | 17,500 |
| 02/15/2023 |
Daniel L. Flynn Chief Scientific Officer |
16,488 | Award at $0 per share. | 0 |
| 02/15/2023 |
Matthew L. Sherman EVP & Chief Medical Officer |
16,488 | Award at $0 per share. | 0 |
| 02/15/2023 |
Thomas P. Kelly Chief Financial Officer |
16,488 | Award at $0 per share. | 0 |
| 02/15/2023 |
Daniel C. Martin Chief Commercial Officer |
11,151 | Award at $0 per share. | 0 |
| 02/15/2023 |
Jama Pitman See Remarks |
11,151 | Award at $0 per share. | 0 |
| 02/14/2023 |
Steven L. Hoerter President and CEO; Director |
30,045 | Disposition at $16 per share. | 480,720 |
| 01/24/2023 |
Brightstar Associates LLC |
1,666,666 | Acquisition at $18 per share. | 29,999,988 |
| 01/17/2023 |
Daniel L. Flynn Chief Scientific Officer |
2,403 | Disposition at $21.24 per share. | 51,039 |
| 01/17/2023 |
Matthew L. Sherman EVP & Chief Medical Officer |
2,403 | Disposition at $21.24 per share. | 51,039 |
| 01/17/2023 |
Thomas P. Kelly Chief Financial Officer |
2,403 | Disposition at $21.24 per share. | 51,039 |
| 01/17/2023 |
Daniel C. Martin Chief Commercial Officer |
1,603 | Disposition at $21.24 per share. | 34,047 |
| 01/17/2023 |
Jama Pitman See Remarks |
1,603 | Disposition at $21.24 per share. | 34,047 |
| 10/03/2022 |
Matthew L. Sherman EVP & Chief Medical Officer |
2,587 | Disposition at $18.73 per share. | 48,454 |
| 06/16/2022 |
Daniel L. Flynn Chief Scientific Officer |
1,768 | Disposition at $10.75 per share. | 19,006 |
| 06/16/2022 |
Matthew L. Sherman EVP & Chief Medical Officer |
1,768 | Disposition at $10.75 per share. | 19,006 |
| 06/16/2022 |
Thomas P. Kelly Chief Financial Officer |
1,768 | Disposition at $10.75 per share. | 19,006 |
| 06/16/2022 |
Daniel C. Martin Chief Commercial Officer |
1,311 | Disposition at $10.75 per share. | 14,093 |
| 06/16/2022 |
Jama Pitman See Remarks |
1,298 | Disposition at $10.75 per share. | 13,953 |
| 04/29/2022 |
Brightstar Associates LLC |
1,478,978 | Acquisition at $10 per share. | 14,789,780 |
